Effects of Resveratrol on the Inflammatory Response and Renal Injury in Hyperuricemic Rats

Overview

Journal Nutr Res Pract

Specialty Nutritional Sciences

Date 2021 Feb 5

PMID 33542790

Citations 7

Authors

Benxi Xiao

Wenjun Ma

Ying Zheng

Zhen Li

Dan Li

Yanjun Zhang

Yuanhong Li

Duan Wang

Affiliations

Soon will be listed here.

Abstract

Background/objectives: Hyperuricemic nephropathy is a common cause of acute kidney injury. Resveratrol can ameliorate kidney injury, but the explicit mechanism remains unclear. We investigated the effects of resveratrol on the inflammatory response and renal injury in hyperuricemic rats.

Materials/methods: A rat model of hyperuricemic nephropathy was established by the oral administration of a mixture of adenine and potassium oxinate. Biochemical analysis and hematoxylin and eosin staining were performed to assess the rat kidney function. Enzyme-linked immunosorbent assays were performed to evaluate the immune and oxidative responses.

Results: The expression levels of urine albumin and β2-microglobulin were significantly decreased after resveratrol treatment. In addition, the levels of serum creatinine and uric acid were significantly decreased in the resveratrol groups, compared with the control group. The levels of proinflammatory factors, such as interleukin-1β and tumor necrosis factor-α, in kidney tissue and serum were also increased in the hyperuricemic rats, and resveratrol treatment inhibited their expression. Moreover, the total antioxidant capacity in kidney tissue as well as the superoxide dismutase and xanthine oxidase levels in serum were all decreased by resveratrol treatment.

Conclusions: Resveratrol may protect against hyperuricemic nephropathy through regulating the inflammatory response.

Citing Articles

Establishment and optimization of a novel mouse model of hyperuricemic nephropathy.

Wang J, Chen R, Wu K, Mo J, Li M, Chen Z Ren Fail. 2024; 46(2):2427181.

PMID: 39540397 PMC: 11565683. DOI: 10.1080/0886022X.2024.2427181.

A PDE1 inhibitor, vinpocetine, ameliorates epithelial-mesenchymal transition and renal fibrosis in adenine-induced chronic kidney injury in rats by targeting the DNMT1/Klotho/β-catenin/Snail 1 and MMP-7 pathways.

Abdelfattah A, Mohammed Z, Talaat A, Samy W, Eldesoqui M, Elgarhi R Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39276250 DOI: 10.1007/s00210-024-03393-0.

Resveratrol inhibits calcium oxalate crystal growth, reduces adhesion to renal cells and induces crystal internalization into the cells, but promotes crystal aggregation.

Peerapen P, Putpeerawit P, Boonmark W, Thongboonkerd V Curr Res Food Sci. 2024; 8:100740.

PMID: 38694557 PMC: 11061250. DOI: 10.1016/j.crfs.2024.100740.

Implication of MAPK, Lipocalin-2, and Fas in the protective action of liposomal resveratrol against isoproterenol-induced kidney injury.

Alhusaini A, Alshehri S, Sarawi W, Alghibiwi H, Alturaif S, Al Khbiah R Saudi Pharm J. 2024; 32(1):101907.

PMID: 38178854 PMC: 10764257. DOI: 10.1016/j.jsps.2023.101907.

A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia.

Zhou Y, Zeng Y, Pan Z, Jin Y, Li Q, Pang J Nutrients. 2023; 15(3).

PMID: 36771199 PMC: 9921501. DOI: 10.3390/nu15030492.

References

Ibrahim A, Al-Hizab F, Abushouk A, Abdel-Daim M . Nephroprotective Effects of Benzyl Isothiocyanate and Resveratrol Against Cisplatin-Induced Oxidative Stress and Inflammation. Front Pharmacol. 2018; 9:1268. PMC: 6258716. DOI: 10.3389/fphar.2018.01268. View

Wu M, Gu J, Mei S, Xu D, Jing Y, Yao Q . Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation. Nephrol Dial Transplant. 2016; 31(11):1826-1834. DOI: 10.1093/ndt/gfw058. View

Pan Q, Ren Y, Zhu J, Hu Y, Zheng J, Fan H . Resveratrol increases nephrin and podocin expression and alleviates renal damage in rats fed a high-fat diet. Nutrients. 2014; 6(7):2619-31. PMC: 4113760. DOI: 10.3390/nu6072619. View

He T, Guan X, Wang S, Xiao T, Yang K, Xu X . Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway. Mol Cell Endocrinol. 2014; 402:13-20. DOI: 10.1016/j.mce.2014.12.010. View

Ghei M, Mihailescu M, Levinson D . Pathogenesis of hyperuricemia: recent advances. Curr Rheumatol Rep. 2002; 4(3):270-4. DOI: 10.1007/s11926-002-0076-z. View

Wang Y, Wang B, Qi X, Zhang X, Ren K . Resveratrol Protects Against Post-Contrast Acute Kidney Injury in Rabbits With Diabetic Nephropathy. Front Pharmacol. 2019; 10:833. PMC: 6675867. DOI: 10.3389/fphar.2019.00833. View

Bienholz A, Mae Pang R, Guberina H, Rauen U, Witzke O, Wilde B . Resveratrol Does Not Protect from Ischemia-Induced Acute Kidney Injury in an in Vivo Rat Model. Kidney Blood Press Res. 2017; 42(6):1090-1103. DOI: 10.1159/000485606. View

Chen Y, Fu Y, Wu M . Does Resveratrol Play a Role in Decreasing the Inflammation Associated with Contrast Induced Nephropathy in Rat Model?. J Clin Med. 2019; 8(2). PMC: 6406726. DOI: 10.3390/jcm8020147. View

Soussi D, Danion J, Baulier E, Favreau F, Sauvageon Y, Bossard V . Vectisol Formulation Enhances Solubility of Resveratrol and Brings Its Benefits to Kidney Transplantation in a Preclinical Porcine Model. Int J Mol Sci. 2019; 20(9). PMC: 6540035. DOI: 10.3390/ijms20092268. View

10.

Fidan C, Kantar A, Baskin E, Gulleroglu K, Akdur A, Moray G . Effects of hyperuricemia on renal function in pediatric renal transplant recipients. Exp Clin Transplant. 2015; 13 Suppl 1:247-50. View

11.

Erkasap S, Erkasap N, Bradford B, Mamedova L, Uysal O, Ozkurt M . The effect of leptin and resveratrol on JAK/STAT pathways and Sirt-1 gene expression in the renal tissue of ischemia/reperfusion induced rats. Bratisl Lek Listy. 2017; 118(8):443-448. DOI: 10.4149/BLL_2017_086. View

12.

Ramalingam A, Santhanathas T, Ali S, Zainalabidin S . Resveratrol Supplementation Protects Against Nicotine-Induced Kidney Injury. Int J Environ Res Public Health. 2019; 16(22). PMC: 6888267. DOI: 10.3390/ijerph16224445. View

13.

Cigremis Y, Akgoz M, Ozen H, Karaman M, Kart A, Gecer M . Resveratrol ameliorates cisplatin-induced oxidative injury in New Zealand rabbits. Can J Physiol Pharmacol. 2015; 93(8):727-35. DOI: 10.1139/cjpp-2014-0420. View

14.

Baur J, Sinclair D . Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5(6):493-506. DOI: 10.1038/nrd2060. View

15.

Kitada M, Kume S, Imaizumi N, Koya D . Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes. 2011; 60(2):634-43. PMC: 3028365. DOI: 10.2337/db10-0386. View

16.

Den Hartogh D, Tsiani E . Health Benefits of Resveratrol in Kidney Disease: Evidence from In Vitro and In Vivo Studies. Nutrients. 2019; 11(7). PMC: 6682908. DOI: 10.3390/nu11071624. View

17.

Lim A, Teng G . Allopurinol: a necessary evil. Singapore Med J. 2009; 50(9):925-6. View

18.

Denek Z, Erbil G, Ozbal S, Cilaker Micili S, Ozogul C . The effects of resveratrol against trifluralin toxicity in the urinary tract of rats. Toxicol Ind Health. 2013; 32(1):106-17. DOI: 10.1177/0748233713498437. View

19.

Bekpinar S, Karaca E, Yamakoglu S, Alp-Yildirim F, Olgac V, Uydes-Dogan B . Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin-angiotensin system. Can J Physiol Pharmacol. 2019; 97(12):1115-1123. DOI: 10.1139/cjpp-2018-0753. View

20.

Li J, Li L, Wang S, Zhang C, Zheng L, Jia Y . Resveratrol Alleviates Inflammatory Responses and Oxidative Stress in Rat Kidney Ischemia-Reperfusion Injury and H2O2-Induced NRK-52E Cells via the Nrf2/TLR4/NF-κB Pathway. Cell Physiol Biochem. 2018; 45(4):1677-1689. DOI: 10.1159/000487735. View